Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04287816
Other study ID # 2019H0504-A
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2021
Est. completion date August 2024

Study information

Verified date February 2024
Source Ohio State University
Contact Richard S Bruno, Ph.D.
Phone 614-292-5522
Email bruno.27@osu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Malnutrition of the fat-soluble nutrients vitamin E (α-tocopherol; αT) and vitamin K (phylloquinone; PQ) is problematic. Since αT and PQ are rich in plant foods (e.g. spinach) that are mostly absent of accessible lipid, dietary patterns that can potentiate αT and PQ bioavailability by pairing vegetables with lipid-rich foods have been emphasized. The purpose of this study is to use deuterium-labeled spinach (containing stable isotopes of αT and PQ) to validate eggs as a dietary tool to improve αT and PQ bioavailability directly from a model plant food, and hence achieve nutrient adequacy. It is expected that compared with deuterium-labeled spinach alone, co-ingestion of eggs will dose- and time-dependently increase plasma bioavailability of spinach-derived deuterium-labeled αT and PQ without affecting time to maximal concentrations or half-lives. The outcome will therefore support an egg-based food pairing that can enhance the health benefits of plant-centric dietary patterns.


Description:

In the US, 92-96% and 43-63% of men and women do not meet recommended intakes for αT and PQ, respectively. Dietary recommendations strongly encourage a diet rich in fruits and vegetables to meet dietary αT and PQ requirements. However, αT and PQ bioavailability from most plant foods is quite poor, thereby emphasizing a need for effective food pairings that can enhance the absorption and promote adequate status of these health-promoting nutrients. The objective of this application is to use deuterium-labeled spinach (containing stable isotopes of αT and PQ) to validate eggs as a dietary tool to improve αT and PQ bioavailability directly from a model plant food, and hence achieve nutrient adequacy. Our hypothesis is that the bioavailability of αT and PQ from deuterium-labeled spinach will be potentiated by egg intake in a dose-dependent manner by increasing their secretion in intestinal-derived chylomicrons. To test this, our specific aim is to assess egg-mediated improvements in αT and PQ bioavailability by conducting a randomized cross-over pharmacokinetic study in healthy men and women. In Study Arms 1-4, participants will ingest deuterium-labeled spinach (containing 2 mg αT and 500 μg PQ) with 0, 1, 2, or 3 hardboiled eggs (containing 0, 4.8, 9.6, or 14.4 g total fat, respectively). In Study Arm 5, participants will ingest spinach alone followed by 1 egg 3-hours later. In Study Arm 6, participants will ingest spinach with 1 egg followed by another egg 3-hours later. Thus, Study Arms 1-4 will test the dose-dependent effects of eggs on nutrient bioavailability and Study Arms 5-6 (with comparison to Study Arms 1 and 2) will test the 'timing'-dependent effects of eggs on nutrient bioavailability. Eucaloric diets will be controlled for αT and PQ intakes for 3 d prior to and during the initial 24 h of each trial to minimize heterogeneity of pharmacokinetic responses. Spinach-derived deuterium-labeled αT and PQ will be measured in plasma and isolated chylomicrons collected at timed intervals from 0-72 h post-meal ingestion, and biomarkers of antioxidant status and oxidative distress will be assessed at baseline (0 h) of each trial. Outcomes from this study are expected to demonstrate a dose- and time-dependent function of eggs to increase deuterium-labeled αT and PQ bioavailability (based on AUC0-72 h, Cmax, and % estimated absorption). The rationale for this study is that, by establishing the efficacy of eggs to potentiate plant-derived fat-soluble nutrient bioavailability, a strong framework will exist for an easily implementable health-promoting food pairing strategy to overcome malnutrition of αT and PQ.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Body Mass Index (BMI) = 19-25 kg/m2 - Normolipidemic (total cholesterol <240 mg/dL; triglyceride <150 mg/dL) - Fasting glucose <100 mg/dL - Normal hematocrit level (41%-50% for men and 36%-48% for women) - Normal hemoglobin level (13.5-17.5 g/dL for men and 12.0-15.5 g/dL for women) - No use of dietary supplements for >1 month - No use of medications that affect lipid or glucose metabolism - Non-smoker - No history of gastrointestinal disorders Exclusion Criteria: - Egg allergy - Alcohol intake > 2 drinks per day - Aerobic activity >7 h/wk - Body mass change >2 kg in the past 1 month - Women who are pregnant, lactating, or initiated or changed birth control in the past 3 month - Vegetarian

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Zero hard-boiled egg at 0 h
No eggs will be consumed on test day along with spinach consumption
One hard-boiled egg at 0 h
One egg will be consumed on test day along with spinach consumption
Two hard-boiled eggs at 0 h
Two eggs will be consumed on test day along with spinach consumption
Three hard-boiled eggs at 0 h
Three eggs will be consumed on test day along with spinach consumption
One hard-boiled egg at 3 h
One egg will be consumed on test day three hours after spinach consumption
One hard-boiled egg at 0 h + One hard-boiled egg at 3 h
Two eggs will be consumed on test day: one along with spinach consumption and the other one three hours after spinach consumption

Locations

Country Name City State
United States Ohio State University Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Vitamin C Baseline plasma vitamin C concentration Prior to (0 hour) spinach consumption
Other Malondialdehyde Baseline plasma malondialdehyde concentration Prior to (0 hour) spinach consumption
Primary Vitamin E Bioavailability Area under the curve of deuterium-labeled alpha-tocopherol 0, 3, 4.5, 6, 7.5, 9, 12, 24, 36, 48, 72 hours post-ingestion of spinach
Primary Vitamin E Cmax Maximum plasma concentration of deuterium-labeled alpha-tocopherol 0-72 hours post-ingestion of spinach
Primary Estimated Absorption (%Dose) of Vitamin E Absorption of deuterium-labeled alpha-tocopherol 0-72 hours post-ingestion of spinach
Primary Vitamin K Bioavailability Area under the curve of deuterium-labeled phylloquinone 0, 3, 4.5, 6, 7.5, 9, 12, 24, 36, 48, 72 hours post-ingestion of spinach
Primary Vitamin K Cmax Maximum plasma concentration of deuterium-labeled phylloquinone 0-72 hours post-ingestion of spinach
Primary Estimated Absorption (%Dose) of Vitamin K Absorption of deuterium-labeled phylloquinone 0-72 hours post-ingestion of spinach
Secondary Vitamin E Tmax Time to reach maximum plasma concentration of deuterium-labeled alpha-tocopherol 0-72 hours post-ingestion of spinach
Secondary Chylomicron Vitamin E Deuterium-labeled alpha-tocopherol concentration in chylomicron 0, 3, 4.5, 6, 7.5, 9, 12 hours post-ingestion of spinach
Secondary Elimination Rate of Vitamin E Rate of plasma elimination of deuterium-labeled alpha-tocopherol 0-72 hours post-ingestion of spinach
Secondary Vitamin K Tmax Time to reach maximum plasma concentration of deuterium-labeled phylloquinone 0-72 hours post-ingestion of spinach
Secondary Chylomicron Vitamin K Deuterium-labeled phylloquinone concentration in chylomicron 0, 3, 4.5, 6, 7.5, 9, 12 hours post-ingestion of spinach
Secondary Elimination Rate of Vitamin K Rate of plasma elimination of deuterium-labeled phylloquinone 0-72 hours post-ingestion of spinach
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05489666 - Effects of Vitamin D on Skeletal Muscle Strength in Resistance Trained Adult Females N/A
Completed NCT00803699 - Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels N/A
Completed NCT03279315 - An Iodine Balance Experiment N/A
Recruiting NCT06074770 - Study on Dietary Intake Levels of Iodine for 3-6 Years Old Pre-school Children
Completed NCT00292812 - Clinical Effects of a Nucleotides-Supplemented Infant Formula N/A
Active, not recruiting NCT04286321 - Achieving Nutritional Adequacy Of Vitamins E and K With An Egg/Plant-Based Food Pairing - Study 2 N/A
Completed NCT04419103 - Study on Physiologic Requirement and Dietary Recommended Nutrient Intake (RNI) of Iodine in Children
Recruiting NCT04492657 - Study on the Compensatory Mechanism of Iodine Nutrition and the Optimal Intake Level of Lactating Women
Not yet recruiting NCT05730803 - Displacement of Iodine Balance Value During Pregnancy and the Mechanism of Breast Iodine Homeostasis During Lactation